Clinical Trial Update: Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

View source ↗

Summary

An update on a clinical trial comparing erlotinib to gemcitabine plus cisplatin as neoadjuvant chemotherapy for non-small cell lung cancer; current status is te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non-small Cell Lung Cancer | Status: TEMPORARILY_NOT_AVAILABLE